SEC Filing Analysis: CareDx, Inc. (CDNA)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director, Gunasekaran Suresh, was awarded 27,453 Restricted Stock Units (RSUs) as part of a standard compensation package.
• Market Impact: Neutral. This is a non-cash, non-market transaction with minimal dilutive impact, unlikely to influence short-term price action.

Company Information

Field	Value
Company	CareDx, Inc.
Ticker Symbol	CDNA
CIK	0001217234
Industry	SERVICES-MEDICAL LABORATORIES

Insider Information

Field	Value
Name	Gunasekaran Suresh
CIK	0002093388
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-22
Transaction Code	A (Grant)
Security Type	Common Stock (as RSUs)
Shares Involved	27,453
Price Per Share	$0.00
Total Value	$0
Shares Owned After	27,453
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.00%
Shares Transacted	27,453
% of Shares Outstanding	0.052%
Post-Transaction Ownership	27,453 shares (0.052% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is $0, making it immaterial against the company's $0.81 billion market capitalization.
• Ownership Concentration: This grant establishes the director's initial direct holding in the company, which is a very small fraction (0.052%) of the total shares outstanding.
• Dilution Impact: The issuance of 27,453 shares represents a potential dilution of approximately 0.052% to existing shareholders. This is a negligible level of dilution for a company of this size.
• Transaction Significance: The transaction is classified as 'Low' significance. It is a standard equity award for board service, not an open-market purchase or sale, and its size relative to shares outstanding is minimal.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants to directors are routine and expected forms of compensation. They do not signal new information about the company's prospects and are not market-moving events.

Volume & Sentiment

• Expected Volume Impact: None. This was not an open-market transaction.
• Sentiment Indicator: Neutral. The filing is informational and aligns with standard corporate governance practices.

Investment Insights

Positive Market Indicators

• Aligns insider interests with those of shareholders over the long term due to the vesting schedule.

Risk Factors

• No immediate risk factors are apparent from this routine filing.

Key Takeaways

1. Routine Compensation: This is a standard grant of RSUs to a director for their service.
2. No Market Signal: The transaction was executed at $0 per share and is not an open-market trade, thus it does not reflect the insider's current sentiment on the stock's valuation.
3. Minimal Dilution: The number of shares granted is very small relative to the total shares outstanding, resulting in a negligible dilutive effect.

Additional Context

Transaction Notes

• Vesting Schedule: The filing footnote indicates the RSUs vest in equal annual installments over three years, contingent on the director's continued service. This structure is designed to retain board talent.
• Security Type: The securities are Restricted Stock Units (RSUs), which represent a contingent right to receive shares in the future upon vesting.